BB Biotech AG (BBZA.DE) XETRA

49.55

+0.7(+1.43%)

Updated at December 05 12:11PM

Currency In EUR

Valuation

Market Cap1.94B
Enterprise Value2.05B
P/E Ratio-5.7
PEG Ratio1.93
Price/Sales Ratio-14.19
Price/Book Ratio1.36
Enterprise/Revenue-14.18
Enterprise/EBITDA0

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin2.49
Operating Margin0.3

Management Effectiveness

Return On Assets-0.24
Return On Equity-0.21

Income Statement

Revenue111.63M
Revenue/Share-3.22
Gross Profit111.63M
EBITDA80.24M
Net Income75.9M
Diluted EPS1.38

Balance Sheet

Total Cash2.16M
Total Cash/Share0.04
Total Debt0
Total Debt/Equity0
Current Ratio758.29
Book Value Per Share33.64

Price History

52-Week Change21.52
52-Week High49.05
52-Week Low25.65
Moving Average 50 Days43.56
Moving Average 200 Days36.1

Statistics

Average Volume14,194
Shares Outstanding63.38M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1.8
Trailing Annual Dividend Yield3.94
Payout Ratio-0.22
Last Split Factor5:1
Last Split DateMarch 29, 2016